Insight & Intelligence™

More »
Dec 30, 2011

2011 IPO Window for Biotechs Lets Through Fewer Companies

Just 13 firms went public compared to 16 in 2010, but discounts were smaller.

2011 IPO Window for Biotechs Lets Through Fewer Companies

Due to market volatility, more firms may go the M&A route rather than flocking to public markets. [© Lane Erickson - Fotolia.com]


  • Add a comment
  • Click here to Login or to Register for free. You will be taken back to your selected item after Login/Registration.

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll